Amgen, Inc. (NASDAQ:AMGN)

Top Analyst Upgrades and Downgrades: Amgen, Aramark, Chevron, Deere, Exxon, Hecla, Occidental, Urban Outfitters, Whiting and More

Stocks were very volatile in the prior week after the worst one-day sell-off of 2019, but a late-week recovery is being followed by broad gains on Monday as long-term Treasury ...
Read Full Story »

Friday’s Top Analyst Upgrades and Downgrades: Walmart, Nvidia, Amgen, Applied Materials, Alibaba, Intel, Merck and More

This has been a rough week for the broad markets, with the S&P 500 and Dow Jones industrial average each down about 3% on last look. What’s shocking is that ...
Read Full Story »

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Over the past three decades, the unlimited investing potential of biotechnology was all about growth. Companies could grow from nothing to see untold billions of dollars selling cures and treatments ...
Read Full Story »

Short Sellers Make a Move on Big Biotechs

The short interest data are out for the most recent settlement date, July 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Why Amgen Is Up Despite Falling Product Sales

When Amgen Inc. (NASDAQ: AMGN) released its second-quarter financial results after the markets closed on Tuesday, the firm said that it had $3.97 in earnings per share (EPS) and $5.9 ...
Read Full Story »

Major Biotechs See Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, July 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the most recent settlement date, June 28. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Big Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, June 14. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Big Biotechs Have Short Sellers on the Run

The short interest data are out for the most recent settlement date, May 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Credit Suisse Calls Out Amgen as Its Key Cancer Winner From ASCO

It has been a tough year for many members of the so-called big pharma and big biotech. Also, in recent years, the lines separating the largest biotechs from the largest ...
Read Full Story »

Major Biotechs See a Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, May 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Citigroup Sees Big Upside for 2 of the Largest Biotechs

After quite some time of muted or negative performance, big biotech may be worth a look again. Citigroup analyst Mohit Bansal assumed coverage of the large-cap biotech space and sees ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AK Steel, Amgen, Booking, Chubb, Chipotle, Expedia, Gilead, Goodyear, Philip Morris, Target, Zscaler and More

Stocks were indicated to open lower by about 1%, with the excuse being the same concerns about a trade war with China. Many investors have to be considering if "sell ...
Read Full Story »

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

Although the broad markets have been in a slump recently amid China trade talks, the S&P 500 and Dow futures for Tuesday morning were relatively positive. While there has been ...
Read Full Story »

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, April 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »